Injectable products, “quantum biofeedback,” undeclared equipment, and treatments offered in a murky regulatory landscape. The first inspections of private health facilities by the National Transparency Authority (EAD) are opening a new chapter in the oversight of the health services market.
Specifically, a total of 118 facilities and health service providers have come under the Authority’s scrutiny, as part of an inspection program focused on online references to medical services. Eight inspections are already underway, while joint teams have been formed, in cooperation with the Independent Authority for Market Control and Consumer Protection, to inspect another 17 providers that have been the subject of complaints. Of these, four inspections are already in progress.
The first findings came from on-site inspections on September 21, 2026, and, as Health Minister Adonis Georgiadis clarified in a post, they are indicative and preliminary. At a clinical pathologist’s practice, inspectors found a laboratory operating without the scientific director present. In the refrigerator holding supplies, they found six types of injectable products, including hyaluronic acid, fillers, and exosomes, which are used for aesthetic medical procedures.
According to the clinical pathologist, the products were for personal use. Inspectors requested purchase receipts, which were not provided. At the same time, a social media advertisement for the laboratory referred to aesthetic dermatology services.
At a “Naturopathic Care Center,” inspectors found colon hydrotherapy machines, a bioresonance device, and devices for visceral fat removal and lipolysis. This business had also been inspected by the EAD in 2024, and the report at the time was forwarded to the Ministry of Health, the Central Health Council (KESY), and the Prosecutor’s Office for action within their respective areas of responsibility.
At another private practice, whose scientific director is a doctor without a specialty, inspectors found injectable products, including polypeptides and vitamins, along with purchase records from a pharmacy in Germany that listed patient names. The premises also included two acupuncture rooms, machines for cell “activation/regeneration,” and body analysis equipment. During the inspection, a nursing assistant was administering injectable treatments in the presence of the doctor.
Inspectors also visited a provider of “quantum biofeedback” services. They found three machines which, according to the provider, are used to identify sources of stress in the body. No products were found on the premises, while in a social media video the space was presented as a “medical practice.” No degree recognized in Greece was presented.
Finally, at a multi-specialty clinic licensed as a cardiology and internal medicine practice, a diagnostic laboratory for biological samples, and an imaging laboratory, inspectors found that the obstetrics-gynecology and plastic reconstructive surgery practices included in its license had ceased operating. The EAD stated that there were no signs that the clinic was operating in violation of its license.
